🇺🇸 FDA
Pipeline program

CT-0508

101

Phase 1 mab active

Quick answer

CT-0508 for HER2-positive is a Phase 1 program (mab) at Carisma Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Carisma Therapeutics
Indication
HER2-positive
Phase
Phase 1
Modality
mab
Status
active

Clinical trials